News | August 22, 2014

Proton Therapy Offers Safe, Long-term Treatment for Hodgkin Lymphoma

Findings of the new American study correspond to the results of Proton Therapy Center Czech

Proton Therapy Safe Long-term Treatment Hodgkin Lymphoma Study Florida

August 22, 14 — The data by the University of Florida Proton Therapy Institute (UFPTI) shows a three-year relapse-free rate of 93 percent and a three-year event-free rate of 87 percent. "This study reinforces proton therapy as a safe alternative to the more conventional forms of radiation," said lead researcher Bradford S. Hoppe, M.D., radiation oncologist at the UF Proton Therapy Institute and assistant professor in the University of Florida College of Medicine department of radiation oncology.

The study continues to add to the mounting evidence supporting the use of proton radiation therapy for positive long-term treatment outcomes and quality of life of oncology patients. For instance, none of the patients developed grade three or higher toxicity during follow-up. The UFPTI specialists agreed that the use of proton therapy following chemotherapy in patients with Hodgkin lymphoma has a success rate similar to the conventional treatments with a reduction of radiation outside of the target area, or "involved-node," potentially reducing the risk of late effects caused by radiation.

The study tracked 15 patients between September 2009 and June 2013 with newly diagnosed Hodgkin lymphoma as they received involved-node proton therapy (INPT), which specifically targets initially involved lymph node(s) containing the Hodgkin lymphoma, after completing chemotherapy. Further, the study evaluated the radiation dose in the surrounding healthy tissue as a result of proton therapy compared with conventional treatments, called intensity-modulated radiation therapy (IMRT) and three-dimensional conformal radiation therapy (3DCRT).

Despite some success in treating patients with Hodgkin lymphoma, many patients suffer from late effects of radiation therapy and chemotherapy treatment, including the possible onset of breast cancer or heart disease. "Proton therapy, as opposed to similar conventional photon therapy, reduced the risk of long-term side effects by reducing or eliminating radiation doses to healthy tissue without compromising the cure rate," said lead researcher Bradford S. Hoppe.

The clinical results of Proton Therapy Center Czech, based on treatment of dozens of patients with Hodgkin lymphoma, correspond with the findings of the American study. “Proton therapy was approved for its clinical use in 1992 and has been used for treatment of selected stages of Hodgkin and non-Hodgkin lymphoma based on NCCN guidelines (National Comprehensive Cancer Network) since 2013,” adds doctor Jiri Kubes, Ph.D., the head of proton therapy at PTC Czech.

Comparison of treatment plans is the right and standard process used in radiation oncology, which enables us to foresee the possible risk of side effects and decide for the most appropriate treatment for each patient. This type of data is also important for examining the effectiveness of radiotherapy in general. Based on the international statistics, radiotherapy should be used for more than 50 percent of oncology patients during their treatment,” said Kubeš.

For more information: www.medicalnewstoday.com/releases/278648.php, www.lymphoma.eu.com

Related Content

More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Feature | Proton Therapy | March 06, 2018 | By Jeff Zagoudis
Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
IBA Announces First Patient Treated with Proteus PLUS in The Netherlands
News | Proton Therapy | January 25, 2018
January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG)
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init